Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04959630
Other study ID # B6702020000275
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date June 15, 2021

Study information

Verified date July 2021
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Investigators hypothesize that a virtual reality (VR) environment enhances general surgery residents' performance compared to Desktop Interface (DI)-based visualization of 3D models in decision making for patients with liver tumors. To determine this, a proficiency-based stepwise training curriculum for preoperative planning has been developed using both modalities. The overall objective of the curriculum is that by the end of the training program, residents would be able to formulate a treatment plan for patients with liver tumors.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date June 15, 2021
Est. primary completion date April 19, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: • General surgery residents irrespective of their postgraduate year Exclusion Criteria: - No inform consent - Residents of other specialties

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Clinical decision making based on visualizing liver 3D models in Virtual Reality (VR) environment or via a Desktop Interface (DI)
Visualizing 3D models of livers for preoperative surgical planning via two different environment: DI and VR in sequential order

Locations

Country Name City State
Belgium Ghent University Hospital Ghent
Italy Federico II University Naples

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Ghent

Countries where clinical trial is conducted

Belgium,  Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Residents' decision-making accuracy Residents' decision-making accuracy when reviewing patient data and 3D liver models using DI or VR, measured by comparing their performance to experts' opinions.
The measurement tool will be a questionnaire consisting of ten questions, rate of correct answers will be recorded (e.g. 8/10 correct answers) and higher scores mean a better outcome.
Minimum score=0; Maximum score=10.
Immediately after completing the educational intervention
Secondary Cognitive knowledge retention Retention of knowledge assessed by validated multiple choice questions. Questionnaire consisted of 15 questions will be used, rate of correct answers will be recorded (e.g. 8/15 correct answers), and higher scores mean a better outcome.
Minimum score=0; Maximum score=15.
Baseline and immediately after completing the educational intervention
Secondary Residents' scores in recognizing intrahepatic structures and liver segments Assessed by recognizing intrahepatic structures and 8 liver segments. Questionnaire consisted of 22 questions will be used, rate of correct answers will be recorded (e.g. 8/22 correct answers), and higher scores mean a better outcome.
Minimum score=0; Maximum score=22.
Immediately after completing the educational intervention
Secondary Time needed to devise a surgical plan using the DI or VR platform Assessed by total time needed to make decision for 10 patient cases in minutes Immediately after completing the educational intervention
See also
  Status Clinical Trial Phase
Terminated NCT01020812 - Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma Phase 1/Phase 2
Completed NCT06049836 - Holographic Augmented Reality Versus Screen Visualisation of 3D Rendering Models for the Pre-operative Evaluation and Planning of Liver Resections N/A
Completed NCT01135849 - B-Receptor Signaling in Cardiomyopathy N/A
Recruiting NCT04010071 - Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors Phase 2
Recruiting NCT04709445 - Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses N/A
Terminated NCT01151761 - PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation Phase 2
Active, not recruiting NCT04501913 - Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
Withdrawn NCT03818997 - Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer Phase 2
Completed NCT04642664 - Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer Phase 2
Not yet recruiting NCT03760289 - DKN-01/Atezolizumab as Second Line Treatment of biliarY Tract Cancer and in combiNAtion or Not With Paclitaxel as Second Line treatMent of esophagogastrIC Cancer Phase 2
Terminated NCT00767234 - Permission to Collect Blood Over Time for Research N/A